Losartan Potassium and Ezetimibe prescription drug bottles
Check against the official notice below — it lists the full affected range.
Sandoz is recalling bottles of Losartan Potassium and Ezetimibe prescription medications because the bottle caps do not meet child-resistant closure requirements under the Poison Prevention Packaging Act. If a child swallows medication from one of these bottles, it could cause poisoning. The recalled products include Ezetimibe 10mg tablets in 30-count and 90-count bottles and Losartan Potassium 50mg tablets in 30-count bottles, with specific lot numbers expiring between August 2020 and January 2021.
According to the recall notice, consumers who have affected bottles should immediately secure the medications to keep them away from children's sight and reach. Consumers can continue taking their medication as directed and should contact Sandoz for a free replacement child-resistant bottle cap.
Written by software from the official notice below. Not reviewed by a lawyer.
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. The recalled bottles have "Sandoz," the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. The recall includes the following: Recalled Prescription Drugs NDC Numbers Lot Numbers Expiration Date Ezetimibe 10mg Tablets 0781-5690-31 JE4491 Aug-2020 30 count bottle JE4492 Aug-2020 JE4493 Aug-2020 JE4495 Aug-2020 JG0308 Sep-2020 JG0310 Sep-2020 JG0311 Sep-2020 JG0312 Sep-2020 JG5061 Sep-2020 JG5063 Sep-2020 JK8921 Oct-2020 JK8922 Oct-2020 JK8923 Oct-2020 JK8924 Oct-2020 JL5535 Oct-2020 JM2253 Oct-2020 JM2254 Oct-2020 JM2255 Oct-2020 JM2257 Oct-2020 JM2258 Oct-2020 JM2259 Oct-2020 JM5986 Oct-2020 JM5987 Oct-2020 Ezetimibe 10mg Tablets 0781-5690-92 JE4481 Aug-2020 90 count bottle JG0249 Sep-2020 JK8989 Oct-2020 JN0764 Jan-2021 Losartan Potassium 50mg Tablets 0781-5701-31 HV9471 Feb-2020 30 count bottle
Official record: U.S. Consumer Product Safety Commission ↗
Republished from the official source above; details can change — the source record controls.